Sodium nitroprusside is a vasodilatory agent that exerts its effects via the release of nitrous oxide causing a reduction in both preload and afterload. [42] It has a very rapid onset of action ...

New research reveals that sodium nitroprusside (SNP) treatment significantly reduces decay and maintains the appearance of ...

Sodium nitroprusside 0.5mg/mL (in 0.9% sodium chloride); soln for IV infusion; preservative-free. Nipride RTU is supplied in amber-colored, single-dose, 50 mg/100 mL (0.5 mg/mL) Fliptop Vials ...

Case reports and studies have shown a direct correlation between increased ICP and sodium nitroprusside infusion. [43–45] Information regarding the effect of sodium nitroprusside on cerebral ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.